OBJECTIVES: Pulmonary hypertension (PH) is considered a contraindication for lung volume reduction surgery (LVRS). Because, it has been reported that endobronchial lung volume reduction may have a beneficial effect without increased mortality in patients with emphysema and PH, we evaluated its effect on PH in patients undergoing LVRS.
INTRODUCTION
Emphysema is a chronic lung disease that severely limits the patient's quality of life and survival [1] . It has been demonstrated several times that lung volume reduction surgery (LVRS) provides significant benefit in survival, lung function, gas exchange, exercise capacity and quality of life compared to medical treatment [2, 3] . Early functional measurements are thus consistent with significant clinical benefit, and the improvements are sustained [4] . Postoperative mortality rates can be as low as 0 at 90 days after careful patient selection and treatment at experienced centres [4, 5] . To date, pulmonary hypertension (PH) is considered a contraindication for LVRS [6] .
Advanced emphysema may adversely affect cardiovascular function by several different mechanisms. Hypoxemia and destruction of lung tissue leading to decreased cross-sectional area of the pulmonary vasculature may increase pulmonary vascular resistance [7] . PH is a late and serious complication in patients suffering from chronic obstructive pulmonary disease (COPD) and, depending on the definition and setting, it is found in over half of patients with COPD [8] , especially in the presence of emphysema, during exacerbations and exercise.
For a long time, PH has been considered a contraindication for LVRS because of the fear of worsening haemodynamics after further reduction of the pulmonary vascular bed. However, no published data support PH as an explicit contraindication for LVRS. It may also be that improved respiratory mechanics after LVRS have favourable effects on pulmonary haemodynamics. This idea is supported by 2 case series on the beneficial effects of endoscopic lung volume reduction with endobronchial valves on PH and right ventricular function, respectively, with improvement of clinical and haemodynamic parameters without increased post-interventional morbidity and mortality [9, 10] . In this study, we retrospectively analysed the effect of LVRS on PH in a selected subgroup of our cohort.
MATERIALS AND METHODS

Patients
The institutional database at Zurich University Hospital, Switzerland, was searched for patients who underwent LVRS and preoperative and postoperative transthoracic echocardiography (TTE) from January 2014 until June 2016. Patients with only preoperative TTE but no follow-up TTE were called in and scheduled for follow-up echocardiography (Fig. 1) .
All patients referred for LVRS underwent full functional and radiological evaluation and were evaluated by an interdisciplinary team comprising thoracic surgeons and pulmonologists with long-term experience in performing LVRS. See Table 1 for the institutional selection criteria at Zurich.
Preoperative cardiac assessment
In patients with a history suggestive of cardiac disease (high-risk factor profile or angina) and/or the inability to climb more than 1 flight of stairs, preoperative myocardial single-photon emission computed tomography (CT) scans were performed to assess cardiac ischaemia. In patients with an enlarged pulmonary artery evident on a CT scan (based only on visual assessment), Doppler TTE was performed, and pulmonary artery pressure (PAP) was calculated from the peak trans-tricuspid pressure gradient. Systolic pulmonary artery pressure (sPAP) >35 mmHg measured by TTE was considered PH. sPAP >35 mmHg was a strict contraindication for LVRS in patients with homogeneous emphysema. sPAP up to 45 mmHg was tolerated for those with heterogeneous emphysema and severe hyperinflation. There was no right heart catheterization (RHC) in these patients. Usually patients with PH (sPAP in TTE) and homogeneous emphysema were further evaluated by RHC. These patients were not included in this study. 
Surgery
All patients were operated on by unilateral or bilateral videoassisted thoracic surgery (VATS) LVRS or by thoracotomy in the case of adhesions. All operations were initiated by VATS. Targeted lung tissue for resection was chosen based on preoperative radiological assessment and intraoperative findings of trapped air and perfusion. For volume reduction the areas of pulmonary parenchyma exhibiting the greatest destruction were resected with standard staplers. In case of severe adhesions necessitating adhesiolysis with significant air leak at the end of the procedure on the first operated side, the operation was completed. At the end of the operation, 1-2 chest tubes were placed, and negative pressure suction with 5 cm H 2 O was applied. Perioperative prophylactic antibiotics were given for at least 5 days or until the last chest tube was removed.
Follow-up and outcome measures
All pulmonary function tests were performed using a standard body plethysmograph and CO diffusion capacity. The lung function test after 3 months was performed at the institution according to the routine follow-up protocol followed after LVRS.
Further follow-up (survival) was performed via telephone contact with the family doctor or the patients themselves.
The patients were assessed with TTE to measure sPAP before LVRS, which was recorded at baseline.
Every effort was made to have patients who underwent preoperative TTE return for follow-up evaluation by TTE after LVRS, independently of their preoperative results. The effect of LVRS on sPAP and the benefit for lung function were analysed. Postoperative 6-min walk tests and quality-of-life assessments were not routinely performed.
Preoperative arterial blood gas analysis was performed in all patients at least 3 months before LVRS by the referring physician or at our institution. The partial pressures of oxygen and carbon dioxide (pO 2 and pCO 2 , respectively) were included in the analysis. They were compared with the postoperative values, most of obtained 3 months after surgery (n = 24) or between 6 weeks and 4 months post-surgery (n = 6).
Statistical analysis
Descriptive variables are expressed as medians (quartiles) or counts with proportions, unless otherwise specified. Comparisons were done using the Wilcoxon matched pair signed rank test for related samples and the Independent Samples Test for independent samples. A P-value of <0.05 was determined to be significant. The inverse Kaplan-Meier estimation was used to plot survival. The patients were followed until death or until the last visit in our clinic; death was censored.
All data and graphs were produced using SPSS [11] .
Ethical approval
The institutional review board approved this study.
RESULTS
Patients
One hundred and nineteen primary LVRSs were performed at Zurich between January 2014 and June 2016. Fifty-one patients had a preoperative TTE, already available from the referring institution or indicated because of an enlarged pulmonary artery noted on a CT scan. Thirty-six patients had an sPAP <35 mmHg and 15 patients had an sPAP >35 mmHg. Of these, 30 patients (53% men, median age 65, range 44-74) had both pre-and postoperative TTE, the latter after a median of 9.5 months (range 6-40) after LVRS. Ten patients had a preoperative sPAP >35 mmHg and served as the PH group; the remaining 20 patients served as the control group (Fig. 1 ). See Table 2 for baseline data.
Twenty-seven patients had heterogeneous emphysema, as assessed by high-resolution CT. Three control patients had homogeneous emphysema (and sPAP <35 mmHg). All patients in the PH group had heterogeneous emphysema.
Surgery
All patients. Twenty-three of 30 patients were operated on using VATS (76.7%); 13 operations were bilateral (43.3%). One LVRS was initially scheduled as a bilateral procedure but was terminated after the first side showed massive adhesions and the operation had to be converted to open surgery. All patients were extubated in the operation room. No reintubation was necessary.
The median length of hospital stay was 12 days [interquartile range (IQR) [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Nineteen patients (63%) went to the intensive care unit postoperatively; 11 patients went to the intermediate care ward. The median stay in the intensive care unit was 1 day (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The 90-day mortality rate was 0.
The main postoperative complication was a prolonged air leak (chest tube duration >7 days) in 12 patients (40%). Two patients underwent revision surgery for fistula closure (7%). One patient had new onset atrial fibrillation, 1 patient developed pneumonia (successfully treated with antibiotics) and 1 patient had a pneumothorax after chest tube removal and needed a new chest tube.
Pulmonary hypertension group. The median length of hospital stay was 10 days (7.5-18.5) and similar to that of the controls (P = 0.842). Six of 10 patients needed postoperative care in the intensive care unit (60%) for a median of 1 day (range 1-4) without any difference compared to the controls (P = 0.8634). The 90-day mortality rate was zero. The main postoperative complication was prolonged air leak (chest tube duration >7 days) in 4 patients (40%, at a frequency similar to that of the controls, P = 0.4530). Two patients underwent revision surgery for fistula closure (7%). Besides 1 patient with new onset atrial fibrillation, no other complication occurred.
Pulmonary haemodynamics
In the entire patient cohort (30), the median preoperative sPAP decreased from 30 mmHg (IQR 28-39) to a median postoperative sPAP of 25 mmHg (IQR 20-36, P < 0.001). In the PH group, the sPAP decreased from a median of 41 mmHg (IQR 39-47) to a median of 36.5 mmHg (IQR 36.5-39.25, P = 0.042, Fig. 2 ). Patients in the control group showed a decrease from a preoperative median of 28.5 mmHg (IQR 25-30) to a postoperative median of 24.5 mmHg (IQR 20-25, P < 0.001).
Functional results
Patients in the PH group had a 22% improvement in the forced expiratory volume in 1 s (FEV 1 ) 3 months postoperatively. See Table 3 for all lung function values in the PH group. Patients in the control group showed an improvement of FEV 1 of 21% (Table 3) .
Survival
All 119 patients who had LVRS between January 2014 and June 2016 had a median follow-up period of 14 months (range 3-29). Three patients from the control group died during that follow-up period.
The median follow-up period for all 30 patients was 18 months (95% confidence interval 15.949-20.051).
Three patients died during the follow-up period (all of them had preoperative sPAP <35 mmHg). One died 10 months after LVRS; 1 died after 13 months and another, after 20 months. Two died of infectious exacerbation of COPD and the third, of unknown reasons. Figure 3 shows the Kaplan-Meier survival curve for all 30 patients.
Arterial blood gas analysis
The pre-and postoperative values of pO 2 and pCO 2 are shown in Table 4 . There were no significant changes before and after LVRS, either for the PH or for the control group. According to all reports, PH is considered a contraindication for surgical LVRS for patients with emphysema [12] . However, the prevalence of PH in patients with COPD and especially emphysema is as high as 58% [13] with significant impact on survival [13] . The prevalence is particularly high in the advanced stages, although it remains of mild to moderate severity in most of the cases.
COPD is characterized by airflow obstruction that results from an inflammatory process affecting the airways and the lung parenchyma. Pulmonary vascular remodelling in COPD is due to hypoxic pulmonary vasoconstriction, inflammation and endothelial dysfunction that together with the reduced capillary bed in emphysema are the main causes of an increase in PAP [14] . The argument for excluding patients with PH has been that resection of 20-30% of each lung during LVRS impairs an already compromised pulmonary vascular bed and further impairs postoperative PH. From a histological analysis of the pulmonary artery in the resected lung, remodelling of the pulmonary artery that may exist in the remaining lung is possibly one of the important factors preventing postoperative improvement in exercise-induced PH in patients with COPD [14] .
However, according to a few haemodynamic studies during LVRS, there is no or only a minimal effect of LVRS on pulmonary haemodynamics. Haniuda et al. [15] analysed the results from pulmonary function tests and pulmonary haemodynamic studies at rest and during exercise before and 6 months after LVRS (7 patients) and compared the results to those of patients undergoing pulmonary lobectomy (8 patients). Although sPAP in the lobectomy group was markedly increased in the postoperative period by exercise loading, LVRS did not affect postoperative sPAP at rest or during exercise. The cardiac index was not changed by surgery in patients at rest or in those during exercise in either group. Pulmonary artery wedge pressure in the lobectomy group showed no significant change after surgery. However, LVRS actually ameliorated the marked elevation of pulmonary artery wedge pressure observed during exercise (P < 0.01). LVRS markedly increased pulmonary vascular resistance indexed to body surface area at rest (P < 0.05) but not during exercise. Thus, they suggested that LVRS has no or only a minimal effect on the pulmonary vascular bed in contrast to pulmonary lobectomy, which is intended to decrease the pulmonary vascular bed. This might be related to the fact that the vascular bed in patients with emphysema is mainly reduced in the hyperinflated areas, and therefore resection of these areas has minimal impact. This observation was further confirmed in a cardiovascular subanalysis by Criner et al. [16] , conducted at 3 of 17 centres for the National Emphysema Treatment Trial (NETT). They concluded that, in comparison with medical therapy, surgical LVRS was not associated with an increase in PAP. Moreover, Kubo et al. [17] reported no increase in PAP at rest or during exercise 6 months after bilateral LVRS.
In the following discussion, we present our hypothesis to explain the positive impact of LVRS on a decrease in the sPAP: LVRS has been shown to decrease static and dynamic hyperinflation and to improve neuromechanical coupling, respiratory muscle function, exertional dyspnoea and exercise performance. LVRS increases maximal ventilatory capacity as evidenced by increases in both maximal voluntary ventilation and maximal minute ventilation at peak exercise. The positive effects on airflow obstruction have been ascribed to increases in lung elastic recoil or to reductions in total lung capacity and residual volume leading to an increased vital capacity and improvements in respiratory muscle function. Eventually, the decrease of sPAP may be explained by the fact that, with the decrease of lung volume, hypoxic vasoconstriction during exercise, compression of alveolar vessels and/or the left atrium by the hyperinflated lung are decreased after LVRS. This theory is underlined by the findings of Haniuda et al. [15] , who demonstrated that LVRS showed an excellent effect on postoperative pulmonary artery wedge pressure. After LVRS, the marked elevation in pulmonary artery wedge pressure during exercise that was observed before LVRS was significantly ameliorated. The fact that the cardiac index and PAP after LVRS showed no changes in the analysis cited, may be related to the selection of an avascular area of the lung on the preoperative perfusion scan. As to hypoxic pulmonary vasoconstriction, Kubo et al. [17] demonstrated that oxygen administration significantly decreased PAP during exercise before and after LVRS. Therefore, improvement in dynamic hyperinflation induced by LVRS may affect the supply of oxygen to the remaining lung and decrease PA pressures. High CO 2 levels may induce PH [18] . We did not find significant differences between our patients with PH and the control group, but we will follow up this issue in our prospective study.
CONCLUSIONS
It is evident that our findings, which arise from a retrospective analysis of a highly selected group of our LVRS cohort, have several limitations. Besides the well-known limitations of a retrospective analysis, the scheduling of assessment with TTE after LVRS varied, and TEE was not performed in a standardized, systematic way. Furthermore, assessment of sPAP by TTE depends on the presence and quality of tricuspid regurgitation and on the experience of the examiner, the oxygenation and the fluid status of the patient. Moreover, TTE is not as sensitive as RHC, particularly when the patient presents with hyperinflated lungs, but we had no RHC data available at the time, which we will have in our prospective study. Although these patients even showed improved PAP after LVRS, the results must be interpreted with caution. These results still encourage us to systematically assess pulmonary haemodynamics in patients undergoing LVRS prospectively for further clarification to determine whether mild to moderate PH should no longer be considered as a contraindication for patients with heterogeneous emphysema.
Although improvement of FEV 1 % predicted and decrease of hyperinflation [residual volume (RV) % predicted and residual volume/total lung capacity (RV/TLC %)] are significant, the current study focuses on the feasibility of LVRS in patients with nonhomogeneous emphysema and elevated PAP, whereas lung function values have been published by our group several times previously [19, 20] .
In the published cohort from Columbia University, New York [4] , 15% of patients showed preoperative mPAP values above 25 mmHg. None of the 91 patients died, including those with PH (Mark E. Ginsburg and Joshua Sonett, unpublished data).
The perioperative outcome and long-term survival and functional results favour the approach of not systematically excluding PH patients from surgical LVRS, especially in the presence of heterogeneous emphysema and relatively moderate PH, and call for a future prospective trial in this relatively frequent patient collective. RHC is not recommended during routine, preoperative evaluation of patients with COPD in whom the presence of PH may have an impact on candidacy for surgery, on selection of type of surgery or on perioperative management [21] . Based on the present data, we changed our policy: We now assess all our patients with emphysema who are being considered for surgical LVRS prospectively with TTE and with RHC in patients with suspected PH to further explore this concept. Our current findings encourage us to consider a broader spectrum of patients with emphysema for LVRS. Patients with mild to moderate PH found on TTE scans should not be excluded apodictically but should at least be investigated further as possible candidates for LVRS.
